Vitor H. Almeida

582 total citations
20 papers, 463 citations indexed

About

Vitor H. Almeida is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Vitor H. Almeida has authored 20 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Hematology. Recurrent topics in Vitor H. Almeida's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), HER2/EGFR in Cancer Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Vitor H. Almeida is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), HER2/EGFR in Cancer Research (5 papers) and Cell Adhesion Molecules Research (4 papers). Vitor H. Almeida collaborates with scholars based in Brazil, Netherlands and Poland. Vitor H. Almeida's co-authors include Robson Q. Monteiro, Araci M. R. Rondon, Cláudia Mermelstein, Maria Isabel D. Rossi, Tainá Gomes, Débora Dummer Meira, Carlos Gil Ferreira, Andréia Cristina de Melo, Rodolpho Mattos Albano and Fausto Gueths Gomes and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Vitor H. Almeida

20 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vitor H. Almeida Brazil 11 235 159 144 97 60 20 463
Nandini Mondal United States 11 380 1.6× 235 1.5× 166 1.2× 66 0.7× 91 1.5× 13 657
Lilach Gutter-Kapon Israel 6 305 1.3× 109 0.7× 139 1.0× 54 0.6× 29 0.5× 6 477
Kerstin Schlüter Germany 9 191 0.8× 109 0.7× 267 1.9× 86 0.9× 21 0.3× 9 505
Bernd Muehlenweg Germany 14 232 1.0× 42 0.3× 171 1.2× 294 3.0× 123 2.0× 19 555
Kristen N. Cordova United States 4 153 0.7× 206 1.3× 85 0.6× 79 0.8× 23 0.4× 5 413
M N Blackburn United States 11 248 1.1× 110 0.7× 75 0.5× 191 2.0× 283 4.7× 13 737
Yanjun Gu China 11 348 1.5× 77 0.5× 166 1.2× 208 2.1× 38 0.6× 24 532
Lindsay J. Bawden United Kingdom 7 222 0.9× 66 0.4× 222 1.5× 167 1.7× 61 1.0× 12 453
D. Berry United States 8 157 0.7× 186 1.2× 41 0.3× 26 0.3× 91 1.5× 12 484
Franziska Leonhardt Germany 10 145 0.6× 131 0.8× 58 0.4× 93 1.0× 105 1.8× 13 385

Countries citing papers authored by Vitor H. Almeida

Since Specialization
Citations

This map shows the geographic impact of Vitor H. Almeida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vitor H. Almeida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vitor H. Almeida more than expected).

Fields of papers citing papers by Vitor H. Almeida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vitor H. Almeida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vitor H. Almeida. The network helps show where Vitor H. Almeida may publish in the future.

Co-authorship network of co-authors of Vitor H. Almeida

This figure shows the co-authorship network connecting the top 25 collaborators of Vitor H. Almeida. A scholar is included among the top collaborators of Vitor H. Almeida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vitor H. Almeida. Vitor H. Almeida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hottz, Eugênio D., Araci M. R. Rondon, Henri H. Versteeg, et al.. (2023). TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells. Cancers. 16(1). 5–5. 6 indexed citations
2.
Pereira, Denise de Abreu, Vanessa Sandim, Vitor H. Almeida, et al.. (2022). Proteomic Analysis of HCC-1954 and MCF-7 Cell Lines Highlights Crosstalk between αv and β1 Integrins, E-Cadherin and HER-2. International Journal of Molecular Sciences. 23(17). 10194–10194. 9 indexed citations
3.
Gomes, Fausto Gueths, Vitor H. Almeida, Araci M. R. Rondon, et al.. (2021). Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications. Brazilian Journal of Medical and Biological Research. 54(6). e10754–e10754. 2 indexed citations
5.
Melo, Andréia Cristina de, et al.. (2020). Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer. Frontiers in Oncology. 10. 557280–557280. 16 indexed citations
6.
Medeiros, Luciano Neves de, Lycia de Brito‐Gitirana, Pedro G. Pascutti, et al.. (2020). Pisum sativum Defensin 1 Eradicates Mouse Metastatic Lung Nodules from B16F10 Melanoma Cells. International Journal of Molecular Sciences. 21(8). 2662–2662. 10 indexed citations
7.
Almeida, Vitor H., Araci M. R. Rondon, Tainá Gomes, & Robson Q. Monteiro. (2019). Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis. Cells. 8(7). 716–716. 42 indexed citations
8.
Almeida, Vitor H., José Alves Júnior, Márcio Mesquita, et al.. (2018). COMPARAÇÃO DA VIABILIDADE ECONÔMICA DA AGRICULTURA IRRIGADA POR PIVÔ CENTRAL EM SISTEMAS DE PLANTIOS CONVENCIONAL E DIRETO COM SOJA, MILHO E TOMATE INDUSTRIAL. Global Science and Technology. 11(2). 1 indexed citations
9.
Almeida, Vitor H., Fausto Gueths Gomes, Maria Gabriela Berzoti-Coelho, et al.. (2018). Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia. Experimental Hematology. 66. 50–62. 3 indexed citations
10.
Rondon, Araci M. R., Vitor H. Almeida, Tainá Gomes, et al.. (2018). Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications. 502(1). 137–144. 17 indexed citations
11.
Almeida, Vitor H., et al.. (2018). Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells. Biochemical and Biophysical Research Communications. 504(1). 270–276. 12 indexed citations
12.
Almeida, Vitor H., Araci M. R. Rondon, Tatiana Martins Tilli, et al.. (2018). Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer. Oncotarget. 9(55). 30594–30609. 36 indexed citations
13.
Almeida, Vitor H., et al.. (2017). TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo. Biochemical and Biophysical Research Communications. 495(1). 1300–1304. 9 indexed citations
14.
Gomes, Fausto Gueths, Vanessa Sandim, Vitor H. Almeida, et al.. (2017). Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms. Thrombosis Research. 159. 24–32. 75 indexed citations
15.
Almeida, Vitor H., Andréia Cristina de Melo, Débora Dummer Meira, et al.. (2017). Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer. Brazilian Journal of Medical and Biological Research. 51(1). e6822–e6822. 19 indexed citations
16.
Almeida, Vitor H. & Robson Q. Monteiro. (2016). Protease-activated receptor 1 (PAR1): a promising target for the treatment of glioblastoma?. Translational Cancer Research. 5(6). 2 indexed citations
17.
Almeida, Vitor H. & Robson Q. Monteiro. (2016). Protease-activated receptor 1 (PAR1): a promising target for the treatment of glioblastoma?. Translational Cancer Research. 5(S6). S1274–S1280. 7 indexed citations
18.
Meira, Débora Dummer, et al.. (2011). Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab. Molecular Cancer. 10(1). 151–151. 5 indexed citations
19.
Meira, Débora Dummer, et al.. (2009). Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway. European Journal of Cancer. 45(7). 1265–1273. 33 indexed citations
20.
Meira, Débora Dummer, et al.. (2009). Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells. British Journal of Cancer. 101(5). 782–791. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026